[1] del Aguila MA, longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology, 2003, 60(5): 813-819.
[2] 陈文族, 赵振华, 吴志英. 家族性肌萎缩侧索硬化致病基因的研究进展. 中华神经科杂志, 2008, 40(6): 425-428.
[3] 史树贵, 李露斯, 陈康宁, 刘昕. 一个肌萎缩侧索硬化家系的SOD1基因突变. 中华医学遗传学杂志, 2004, 21(2): 149-152.
[4] Zhang HG, Zhao HS, Lu M, Zhang YS, Wang LP, Zhang J, Ma D, Fan DS. A rare Cu/Zn superoxide dismutase mutation causing familial amyotrophic lateral sclerosis with variable age of onset and incomplete penetrance in China. Amyotroph Lateral Scler Other Motor Neuron Disord, 2005, 6(4): 234-238.
[5] Fong GCY, Kwok KHH, Song YQ, Cheng TS, Ho PWL, Chu ACY, Kung MHW, Chan KH, Mak W, Cheung RTF, Ramsden DB, Ho SL. Clinical phenotypes of a large Chinese multigenerational kindred with autosomal dominant familial ALS due to Ile149Thr SOD1 gene mutation. Amyotroph Lateral Scler, 2006, 7(3): 142-149.
[6] Tsai CP, Soong BW, Lin KP, Tu PH, Lin JL, Lee YC. FUS, TARDBP, and SOD1 mutations in a Taiwanese cohort with familial ALS. Neurobiol Ag-ing, 2010, 32(3): 553. e13-e21.
[7] 李晓光, 张莉红, 谢曼青, 刘明生, 李本红, 赵燕环, 崔丽英. 中国家族性肌萎缩侧索硬化患者超氧化物歧化酶1基因突变分析. 中华神经科杂志, 2010, 43(10): 686-691.
[8] Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. EI Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord, 2000, 1(5): 593-599.
[9] Xiong HL, Wang JY, Sun YM, Wu JJ, Chen Y, Qiao K, Zheng QJ, Zhao GX, Wu ZY. Association between novel TARDBP mutations and Chinese patients with amyotrophic lateral sclerosis. BMC Med Genet, 2010, 11: 8.
[10] Chattopadhyay M, Valentine JS. Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS. Antioxid Redox Signal, 2009, 11(7): 1603-1614.
[11] Juneja T, Pericak-Vance MA, Laing NG, Dave S, Siddique T. Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu, Zn superoxide dismutase. Neurology, 1997, 48(1): 55-57.
[12] Saeed M, Yang Y, Deng HX, Hung WY, Siddique N, Dellefave L, Gellera C, Andersen PM, Siddique T. Age and founder effect of SOD1 A4V mutation causing ALS. Neurology, 2009, 72(19): 1634-1639.
[13] Andersen PM, Forsgren L, Binzer M, Nilsson P, Ala-Hurula V, Keränen ML, Bergmark L, Saarinen A, Haltia T, Tarvainen I, Kinnunen E, Udd B, Marklund SL. Autosomal recessive adult-onset amyotrophic lateral scle-rosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and ge-nealogical study of 36 patients. Brain, 1996, 119(Pt4): 1153-1172.
[14] Cudkowicz ME, Mckenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, Schoenfeld DA, Hosler BA, Horvitz HR, Brown RH. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol, 1997, 41(2): 20-21.
[15] Eisen A, Mezei MM, Stewart HG, Fabros M, Gibson G, Andersen PM. SOD1 gene mutations in ALS patients from British Columbia, Canada: Clinical features, neurophysiology and ethical issues in management. Amyotroph Lateral Scler, 2008, 9(2): 108-119.
[16] Suzuki M, Yasui K, Ishikawai H, Nomura M, Watanabe T, Mikami H, Yamano T, Ono S. Familial amyotrophic lateral sclerosis with Cys111Tyr mutation in Cu/Zn superoxide dismutase showing widespread Lewy body-like hyaline inclusions. J Neurol Sci, 2011, 300(1-2): 182-184.
[17] Andersen PM. Amyotrophic lateral sclerosis genetics with mendelian inheritance//Brown RH, Swash M, Pasinelli P, eds. Amyotroph Lateral Scler. 2 nd ed. London: Informa Healthcare, 2006: 187-207.
[18] Millecamps S, Salachas F, Cazeneuve C, Gordon P, Bricka B, Camuzat A, Guillot-Noël L, Russaouen O, Br
